SCHEMBL8842818

SCHEMBL8842818

CCc1ccc(-c2n[nH]c(C(=O)O)c2N)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.51
ALPL P05186 1/20 0.51
CA9 Q16790 1/20 0.51
RAB9A P51151 5/20 0.43
ALDH1A1 P00352 3/20 0.43
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
MAPT P10636 1/20 0.41
NOTUM Q6P988 1/20 0.41
DHODH Q02127 1/20 0.40
CCNE2 O96020 1/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
TP53 P04637 1/20 0.40
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17966223 0.80 ALDH1A1 (0.59) ALPLRAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL6852929 0.75 CA12 (0.50) CA12ALPLCA9RAB9AALDH1A1
SCHEMBL1753182 0.74 HPGDS (0.60) RAB9AALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL11070857 0.72 RXFP1 (0.46) CA12ALPLCA9RAB9AALDH1A1
SCHEMBL8842683 0.72 ALDH1A1 (0.56) CA12ALPLCA9RAB9AALDH1A1
SCHEMBL17966240 0.71 SMN1; SMN2 (0.60) CA12CA9RAB9AALDH1A1SMN1; SMN2
SCHEMBL19625068 0.71 KDM4E (0.55) RAB9AALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL4683639 0.69 GRK6 (0.45) ALDH1A1MAPTNOTUMDHODH
SCHEMBL31014274 0.69 ATM (0.67) RAB9AALDH1A1MAPTKDM4ENPC1
SCHEMBL4678365 0.69 MAP2K4 (0.48) RAB9AHSP90AA1HSP90AB1MAPTNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5674887-A Prevention of bone resorption ELI LILLY AND COMPANY (US) 1997-10-07 US disclosed
EP-0578477-B1 Treatment of inflammatory bowel disease LILLY CO ELI (US) 1996-06-19 EP disclosed
US-5436258-A Prevention of bone resorption ELI LILLY AND COMPANY (US) 1995-07-25 US disclosed
EP-0587378-A1 Prevention of bone resorption ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed
US-5294630-A Treatment of inflammatory bowel disease ELI LILLY AND COMPANY (US) 1994-03-15 US disclosed
EP-0578477-A1 Treatment of inflammatory bowel disease ELI LILLY AND COMPANY (US) 1994-01-12 EP disclosed